ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Gubra (GUBRA.CO)
Gubra stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · Nasdaq Copenhagen · Denmark
DKK 285.20▼ -1.31%
Prices as of Oct 26, 2026 · DKK
Chance of rising in 1 month
48%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Gubra in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Gubra
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Gubra a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between DKK 259.78 and DKK 309.92; in 9 out of 10, between DKK 222.16 and DKK 362.41. Estimated annual volatility is 45%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- DKK 4.8B
- Market cap (USD)
- $716M
- 52-week high
- DKK 557.50
- 52-week low
- DKK 272.00
- Revenue (12 months)
- DKK 271M
- Gross margin
- 75.3%
- Operating margin
- -97.3%
- Net margin
- -67.3%
- Beta
- 0.45
What this means
ATLAS does not publish a fair value for GUBRA.CO right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks GUBRA.CO has traded between DKK 272.00 and DKK 557.50. Today it is 48.8% below that high and 5% above its low.
Its beta is 0.45: it tends to move less than the market.
About the company
Gubra A/S, a disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally. It operates through three segments: Preclinical Contract Research (CRO), Biotech, and Gubra Green.
Want to see everything about Gubra?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Gubra do?
Gubra A/S, a disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally. It operates through three segments: Preclinical Contract Research (CRO), Biotech, and Gubra Green.
What is the chance GUBRA.CO goes up next month?
48%: close to a coin flip. In half of the simulated outcomes, GUBRA.CO ends the month between DKK 259.78 and DKK 309.92.
How big is Gubra and what is its P/E ratio?
Gubra's market capitalization is DKK 4.8B. We do not show a P/E because it has no positive earnings to base one on.
How volatile is GUBRA.CO?
ATLAS estimates annual volatility at 45%. In a typical month, half of the outcomes end between DKK 259.78 and DKK 309.92.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer